Retraction Note: J Exp Clin Cancer Res 38, 139 (2019)
https://doi.org/10.1186/s13046-019-1134-y
The Editor-in-Chief has retracted this article. Concerns have been raised about Fig. 3a, specifically:
-
The 0h control panels for U87 and U251 appear to be identical
-
The 0h NF 25µM panels for U87 and NF 25µM appear to be identical
-
The 0h NF 30 µM panels for U87 and U251 appear to partially overlap
-
The 24h control panels for U87 and U251 appear to be identical
-
The 24h NF 25 µM panels for U87 and U251 appear to partially overlap
-
The 24h NF 30 µM panels for U87 and U251 appear to partially overlap
-
The 48h control panels for U87 and U251 appear to partially overlap
-
The 48 NF 25 µM panels for U87 and U251 appear to be identical
The Editor-in-Chief therefore no longer have confidence in the results and conclusions of this article.
Authors Zizhuo Li and Xiuhua Yang agree with this retraction. The other authors have not responded to correspondence regarding this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-019-1134-y
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, Z., Chen, Y., An, T. et al. Retraction Note: Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway. J Exp Clin Cancer Res 42, 94 (2023). https://doi.org/10.1186/s13046-023-02662-9
Published:
DOI: https://doi.org/10.1186/s13046-023-02662-9